Pharmacological approach of a new isoquinoline derivative (458 L).
D000818:Animals; D002389:Catatonia / Q000139:chemically induced; D006168:Guinea Pigs; D006633:Histamine Antagonists; D006640:Histidine Decarboxylase / Q000037:antagonists & inhibitors; D006801:Humans; D007546:Isoquinolines / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D008297:Male; D051379:Mice; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects; D012110:Reserpine / Q000037:antagonists & inhibitors; D012701:Serotonin / Q000494:pharmacology; D044005:Tetrahydroisoquinolines; D014018:Tissue Distribution
D006633:Histamine Antagonists; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D012701:Serotonin; C030388:458L; D012110:Reserpine; D006640:Histidine Decarboxylase